LAVA Therapeutics NV
NASDAQ:LVTX

Watchlist Manager
LAVA Therapeutics NV Logo
LAVA Therapeutics NV
NASDAQ:LVTX
Watchlist
Price: 1.74 USD Market Closed
Market Cap: 45.8m USD

LAVA Therapeutics NV
Tax Provision

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LAVA Therapeutics NV
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
LAVA Therapeutics NV
NASDAQ:LVTX
Tax Provision
-$630k
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharming Group NV
AEX:PHARM
Tax Provision
-$14.7m
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
ProQR Therapeutics NV
NASDAQ:PRQR
Tax Provision
-€18k
CAGR 3-Years
47%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Uniqure NV
NASDAQ:QURE
Tax Provision
-$10.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
argenx SE
XBRU:ARGX
Tax Provision
$747.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merus NV
NASDAQ:MRUS
Tax Provision
-$11.3m
CAGR 3-Years
-152%
CAGR 5-Years
-113%
CAGR 10-Years
N/A
No Stocks Found

LAVA Therapeutics NV
Glance View

Market Cap
45.8m USD
Industry
Biotechnology

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

LVTX Intrinsic Value
2.52 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is LAVA Therapeutics NV's Tax Provision?
Tax Provision
-630k USD

Based on the financial report for Dec 31, 2024, LAVA Therapeutics NV's Tax Provision amounts to -630k USD.

What is LAVA Therapeutics NV's Tax Provision growth rate?
Tax Provision CAGR 3Y
-58%

Over the last year, the Tax Provision growth was -145%. The average annual Tax Provision growth rates for LAVA Therapeutics NV have been -58% over the past three years .

Back to Top